FDA Inspection
Lianyungang Kangle Pharmaceutical Co., Ltd.Lianyungang Kangle Pharmaceutical Co., Ltd. – FDA Inspection, Sep 19, 2025
Record Details
This FDA Inspection record concerns Lianyungang Kangle Pharmaceutical Co., Ltd., with an inspection on September 19, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- September 19, 2025
- Product Type
- Human Drugs
View Company Profile
ID · d78f33d3-e13d-4ab4-bdd8-f5ba1a4c5cb7
Inspection Facts
- Inspection number
- 1291764
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Lianyungang Kangle Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 15, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lianyungang Kangle Pharmaceutical Co., Ltd.
- FDA Inspection 1149183 - 2019-05-31
- FDA Inspection 981645 - 2016-07-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.